Triple

T9812303
Position Surface form Disambiguated ID Type / Status
Subject aflibercept E238303 entity
Predicate targets P860 FINISHED
Object vascular endothelial growth factor A
Vascular endothelial growth factor A (VEGF-A) is a key signaling protein that promotes the growth of new blood vessels and increases vascular permeability, playing a central role in angiogenesis and various diseases such as cancer and eye disorders.
E823216 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: vascular endothelial growth factor A | Statement: [aflibercept, targets, vascular endothelial growth factor A]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: vascular endothelial growth factor A
Context triple: [aflibercept, targets, vascular endothelial growth factor A]
  • A. platelet-derived growth factor
    Platelet-derived growth factor is a key signaling protein that regulates cell growth, proliferation, and angiogenesis, and plays important roles in wound healing and various pathological conditions such as cancer and fibrosis.
  • B. aflibercept
    Aflibercept is an anti-VEGF biologic drug used primarily to treat neovascular (wet) age-related macular degeneration and other retinal vascular diseases.
  • C. Activase
    Activase is a brand-name form of the clot-dissolving drug alteplase, widely used as a thrombolytic treatment for acute ischemic stroke and certain types of heart attack and pulmonary embolism.
  • D. EGF
    EGF is the ICAO airline designator used to identify American Eagle Airlines in aviation operations and communications.
  • E. IN-2
    IN-2 is the standard postal-style abbreviation used to refer to Indiana's 2nd congressional district in the U.S. House of Representatives.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: vascular endothelial growth factor A
Triple: [aflibercept, targets, vascular endothelial growth factor A]
Generated description
Vascular endothelial growth factor A (VEGF-A) is a key signaling protein that promotes the growth of new blood vessels and increases vascular permeability, playing a central role in angiogenesis and various diseases such as cancer and eye disorders.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: vascular endothelial growth factor A
Target entity description: Vascular endothelial growth factor A (VEGF-A) is a key signaling protein that promotes the growth of new blood vessels and increases vascular permeability, playing a central role in angiogenesis and various diseases such as cancer and eye disorders.
  • A. platelet-derived growth factor
    Platelet-derived growth factor is a key signaling protein that regulates cell growth, proliferation, and angiogenesis, and plays important roles in wound healing and various pathological conditions such as cancer and fibrosis.
  • B. aflibercept
    Aflibercept is an anti-VEGF biologic drug used primarily to treat neovascular (wet) age-related macular degeneration and other retinal vascular diseases.
  • C. Activase
    Activase is a brand-name form of the clot-dissolving drug alteplase, widely used as a thrombolytic treatment for acute ischemic stroke and certain types of heart attack and pulmonary embolism.
  • D. EGF
    EGF is the ICAO airline designator used to identify American Eagle Airlines in aviation operations and communications.
  • E. IN-2
    IN-2 is the standard postal-style abbreviation used to refer to Indiana's 2nd congressional district in the U.S. House of Representatives.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69ca84defac48190abc1148804f184c1 completed March 30, 2026, 2:12 p.m.
NER Named-entity recognition batch_69cdb222ba788190a9085272a3de7852 completed April 2, 2026, 12:02 a.m.
NED1 Entity disambiguation (via context triple) batch_69d1cc63c450819091e57030a48e7d88 completed April 5, 2026, 2:43 a.m.
NEDg Description generation batch_69d1cce3d9d481909eaf7278dfe20955 completed April 5, 2026, 2:45 a.m.
NED2 Entity disambiguation (via description) batch_69d1cd5d1670819085c58ff8889318af completed April 5, 2026, 2:47 a.m.
Created at: March 30, 2026, 8:30 p.m.